Yongshan Zhao

ORCID: 0000-0003-1341-802X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ion channel regulation and function
  • Venomous Animal Envenomation and Studies
  • Advancements in Transdermal Drug Delivery
  • Antibiotic Resistance in Bacteria
  • Nicotinic Acetylcholine Receptors Study
  • Antimicrobial Peptides and Activities
  • Surfactants and Colloidal Systems
  • Computational Drug Discovery Methods
  • Receptor Mechanisms and Signaling
  • Bacterial Genetics and Biotechnology
  • Drug Solubulity and Delivery Systems
  • Epigenetics and DNA Methylation
  • Lung Cancer Treatments and Mutations
  • Material Properties and Processing
  • Escherichia coli research studies
  • Electrospun Nanofibers in Biomedical Applications
  • Plant Disease Management Techniques
  • Dermatology and Skin Diseases
  • Glycosylation and Glycoproteins Research
  • Enzyme Structure and Function
  • Protein Structure and Dynamics
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Block Copolymer Self-Assembly
  • Sirtuins and Resveratrol in Medicine
  • Moyamoya disease diagnosis and treatment

Shenyang Pharmaceutical University
2015-2025

Guangxi Normal University
2025

South China University of Technology
2025

Jiangxi Science and Technology Normal University
2024

University of Copenhagen
2024

Jiangxi University of Science and Technology
2022

Hebei Agricultural University
2011

Jilin Medical University
2008-2010

Beijing University of Technology
2010

Peking University People's Hospital
2010

Drug resistance is the leading problem in non-small-cell lung cancer (NSCLC) therapy. The contribution of histone methylation mediating malignant phenotypes NSCLC well known. However, role drug-resistance mechanisms remains unclear. Here, our data show that EZH2 and G9a, two methyltransferases, are involved drug NSCLC. Gene manipulation results indicate combination G9a promotes tumor growth mediates a complementary manner. Importantly, clinical study demonstrates co-expression both enzymes...

10.1016/j.celrep.2024.113714 article EN cc-by-nc-nd Cell Reports 2024-02-01

Lung cancer is a lethal malignancy lacking effective therapies. Emerging evidence suggests that epigenetic enzyme mutations are closely related to the malignant phenotype of lung cancer. Here, we identified series gain-of-function in histone methyltransferase DOT1L. The strongest them R231Q, located catalytic DOT domain. R231Q can enhance substrate binding ability Moreover, promotes cell growth and drug resistance cells vitro vivo. Mechanistic studies also revealed mutant specifically...

10.1126/sciadv.adc9273 article EN cc-by-nc Science Advances 2023-05-31

Abstract Polo-like kinase 1 (PLK1) signaling drives tumor malignancy and chemotherapy resistance, which is an unmet clinical need. Recruiting PLK1 to the central spindle during anaphase necessary for its function in promoting cancer cell proliferation, achieved by binding microtubule-associated protein regulating of cytokinesis (PRC1) located spindle. However, role PLK1/PRC1 resistance unknown. In this study, we identified a small molecule B4 inhibited through disrupting formation complexes....

10.1038/s41419-025-07708-8 article EN cc-by Cell Death and Disease 2025-05-12

Kidney renal clear cell carcinoma (KIRC) with poor prognosis is the main histological subtype of carcinoma, accounting for more than 80% patients. Most patients are diagnosed at an advanced stage due to being asymptomatic early on. Advanced KIRC has extremely its inherent resistance radiotherapy and chemotherapy. Therefore, a comprehensive understanding molecular mechanisms development effective diagnostic therapeutic strategies urgently needed. In this study, we aimed identify...

10.3390/ijms23094583 article EN International Journal of Molecular Sciences 2022-04-21

Abstract Glutathione peroxidase (GPX) is one of the important members antioxidant enzyme family. It can catalyze reduction hydroperoxides with glutathione to protect cells against oxidative damage. In previous studies, we have prepared human catalytic antibody Se‐scFv‐B3 (selenium‐containing single‐chain Fv fragment clone B3) GPX activity by incorporating a group Sec (selenocysteine) into binding site using chemical mutation; however, its was not very satisfying. order try improve activity,...

10.1002/jmr.946 article EN Journal of Molecular Recognition 2009-03-10

Scorpion venom contains a large variety of biologically active peptides. However, most these peptides have not been identified and characterized. Peptides with three disulfide bridges, existing in the scorpion venom, studied detail poorly characterized until now. Here, we report recombinant expression functional characterization two kinds (BmKBTx BmNaL-3SS2) bridges. This study adopted an effective Escherichia coli system. The genes for BmKBTx BmNaL-3SS2 were obtained by polymerase chain...

10.2174/0929866524666170117142404 article EN Protein and Peptide Letters 2017-01-27
Coming Soon ...